Liver transplantation is not indicated for cholangiocarcinoma

HPB

Volumn 5, Issue 4, 2003, Pages 203-205

  Pinson, C Wright ^a   Moore, Derek E ^a  

^a VANDERBILT UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; FLUOROURACIL; IRIDIUM;

BILE DUCT CARCINOMA; BRACHYTHERAPY; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; EDITORIAL; HISTOPATHOLOGY; HUMAN; IATROGENIC DISEASE; IMMUNOSUPPRESSIVE TREATMENT; LIVER TRANSPLANTATION; MORBIDITY; MORTALITY; PERIOPERATIVE PERIOD; TREATMENT INDICATION;

EID: 0346266238     PISSN: 1365182X     EISSN: None     Source Type: Journal    
DOI: 10.1080/13651820310019938     Document Type: Editorial

References (23)

1. Lee SG, Lee YJ, Park KM, Hwang S, Min PC. One hundred and eleven liver resections for hilar bile duct cancer. J Hepatobiliary Pancreat Surg 2000;7:135-41.
2. Ringe B, Wittekind C, Bechstein WO, Bunzendahl H, Pichlmayr R. The role of liver transplantation in hepatobiliary malignancy. A retrospective analysis of 95 patients with particular regard to tumor stage and recurrence. Ann Surg 1989;209:88-98.
3. Pichlmayr R, Lamesch P, Weimann A, Tusch G, Ringe B. Surgical treatment of cholangiocellular carcinoma. World J Surg 1995;19:83-8.
4. Bismuth H. Revisiting liver transplantation for patients with hilar cholangiocarcinoma: The Mayo Clinic proposal. Liver Transpl 2000;6:317-19.
5. Nashan B, Schlitt HJ, Tusch G, et al. Biliary malignancies in primary sclerosing cholangitis: Timing for liver transplantation. Hepatology 1996;23:1105-11.
6. O'Grady JG, Polson RJ, Rolles K, Calne RY, Williams R. Liver transplantation for malignant disease. Results in 93 consecutive patients. Ann Surg 1988;207:373-9.
7. Shimoda M, Farmer DG, Colquhoun SD, et al. Liver transplantation for cholangiocellular carcinoma: Analysis of a single-center experience and review of the literature. Liver Transpl 2001;7:1023-33.
8. Goss JA, Shackleton CR, Farmer DG, et al. Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience. Ann Surg 1997;225:472-81.
9. Iwatsuki S, Todo S, Marsh JW, et al. Treatment of hilar cholangiocarcinoma (Klatskin tumors) with hepatic resection or transplantation J Am Coll Surg 1998;187:358-64.
10. DeVreede I, Steers JL, Burch PA, et al. Prolonged disease-free survival after orthotopic liver transplantation plus adjuvant chemoirradiation for cholangiocarcinoma. Liver Transpl 2000;6:309-16.
11. Sudan D, DeRoover A, Chinnakotla S, et al. Radiochemotherapy and transplantation allow long-term survival for nonresectable hilar cholangiocarcinoma. Am J Transplant 2002;2:774-9.
12. Meyer CG, Penn I, James L. Liver transplantation for cholangiocarcinoma: Results in 207 patients. Transplantation 2000;69:1633-7.
13. Uenishi T, Hirohashi K, Kubo S, Yamamoto T, Yamazaki O, Kinoshita H. Clinicopathological factors predicting outcome after resection of mass-forming intrahepatic cholangiocarcinoma. Br J Surg 2001;88:969-74.
14. Pinson CW, Rossi RL. Extended right hepatic lobectomy, left hepatic lobectomy, and skeletonization resection for proximal bile duct cancer. World J Surg 1988;12:52-9.
15. Baer HU, Stain SC, Dennison AR, Eggers B, Blumgart LH. Improvements in survival by aggressive resections of hilar cholangiocarcinoma. Ann Surg 1993;217:20-7.
16. Jarnagin WR, Fong Y, DeMatteo RP, et al. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg 2001;234:507-17.
17. Klempnauer J, Ridder GJ, Werner M, Weimann A, Pichlmayr R. What constitutes long-term survival after surgery for hilar cholangiocarcinoma? Cancer 1997;79:26-34.
18. Neuhaus P, Jonas S, Bechstein WO, et al. Extended resections for hilar cholangiocarcinoma. Ann Surg 1999;230:808-18.
19. Lillemoe KD, Cameron JL. Surgery for hilar cholangiocarcinoma: The Johns Hopkins approach. J Hepatobiliary Pancreat Surg 2000;7:115-21.
20. Ogura Y, Kawarada Y. Surgical strategies for carcinoma of the hepatic duct confluence. Br J Surg 1998;85:20-4.
21. Launois B, Terblanche J, Lakehal M, et al. Proximal bile duct cancer: High resectability rate and 5-year survival. Ann Surg 1999;230:266-75.
22. Bismuth H, Nakache R, Diamond T. Management strategies in resection for hilar cholangiocarcinoma. Ann Surg 1992;215:31-8.
23. Madariaga JR, Iwatsuki S, Todo S, Lee RG, Irish W, Starzl TE. Liver resection for hilar and peripheral cholangiocarcinomas: A study of 62 cases. Ann Surg 1998;227:70-9.